{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:19:40Z","timestamp":1778815180436,"version":"3.51.4"},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":199,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Case Reports in Endocrinology"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Graves\u2019 disease is an autoimmune thyroidopathy associated with hyperthyroidism and nonendocrine manifestations such as thyroid eye disease (TED), pretibial myxedema, and thyroid acropachy. Thyroid acropachy is an uncommon but debilitating condition, typically characterized by digital clubbing, soft tissue swelling, and periosteal new bone formation in the hands and feet. This condition often accompanies TED and dermopathy, but effective treatments remain elusive. The first documented case of thyroid acropachy successfully treated with teprotumumab, a monoclonal antibody targeting the insulin\u2010like growth factor\u20101 receptor (IGF\u20101R), is reported here. A 49\u2010year\u2010old female with a history of Graves\u2019 disease developed severe musculoskeletal symptoms, including clubbing and periosteal new bone formation. Despite initial therapies with rituximab and intravenous immunoglobulin showing limited benefit, treatment with teprotumumab, primarily prescribed for TED, led to significant clinical and radiological improvement. After completing eight cycles of teprotumumab, the patient\u2019s musculoskeletal pain resolved, clubbing regressed, and radiologic findings of periosteal bone formation diminished. This case highlights the potential of teprotumumab as a novel therapeutic option for thyroid acropachy and suggests that IGF\u20101R plays a crucial role in its pathogenesis. While this report presents promising results, further studies are needed to confirm the efficacy of teprotumumab in treating thyroid acropachy and better understand its long\u2010term effects on this rare condition.<\/jats:p>","DOI":"10.1155\/crie\/5544869","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T07:19:34Z","timestamp":1752909574000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resolution of Thyroid Acropachy in a Patient Treated With Teprotumumab: A Case Report and Review of Mechanisms"],"prefix":"10.1155","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1498-113X","authenticated-orcid":false,"given":"Soumya","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"e_1_2_8_1_2","first-page":"516","article-title":"Newly Observed Affection of the Thyroid Gland in Females. Clinical Lectures","volume":"7","author":"Graves R. J.","year":"1835","journal-title":"London Medical and Surgical Journal"},{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-01016-5"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-014-0097-2"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.10.001"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020746"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-19-10-1323"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479"},{"key":"e_1_2_8_8_2","unstructured":"Tepezza (teprotumumab) [prescribing information] 2023 Horizon Therapeutics USA Inc."},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2024.102031"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0184-y"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0706"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910434"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-21-0201"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21700"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1580"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080895"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2359"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2518"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.03.013"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.06.002"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54836-w"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225422"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201901719RR"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-102"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15806"},{"key":"e_1_2_8_26_2","unstructured":"ShahS. A. LuT. YuM. HinikerS. DosiouC. andKosslerA. L. Joseph CarrollP. Comparison of Treatment Cost and Quality-of-Life Impact of Thyroid Eye Disease Therapies ARVO Annual Meeting 1\u20134 May 2022 4002\u2013A0344."}],"container-title":["Case Reports in Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crie\/5544869","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/crie\/5544869","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crie\/5544869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T13:52:01Z","timestamp":1772977921000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/crie\/5544869"}},"subtitle":[],"editor":[{"given":"Toshihiro","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1155\/crie\/5544869"],"URL":"https:\/\/doi.org\/10.1155\/crie\/5544869","archive":["Portico"],"relation":{},"ISSN":["2090-6501","2090-651X"],"issn-type":[{"value":"2090-6501","type":"print"},{"value":"2090-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2025-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"5544869"}}